Back

Clinical consequences of atrial fibrillation in pulmonary arterial hypertension: insights from a large real-world cohort

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation epidemiology (1) Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Mahmoud Samy Ahmed

Corewell Health William Beaumont University Hospital, Royal Oak (United States of America)

6 More presentations in this session

Presentation thumbnail
Alcohol use disorder and clinical outcomes in atrial fibrillation: a nationwide cohort study
Mr M. Vanhanen (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Postoperative atrial fibrillation in patients undergoing noncardiac surgery in Alberta: a retrospective cohort study
Doctor Y. Smereka (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Trends of atrial fibrillation/flutter in north africa and middle east from 1990 to 2021 and projections for the next 10 years: an updated systematic analysis of global burden of disease study 2021
Doctor I. Ghayada (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Cancer and atrial fibrillation mortality: worsening national trends over 25 years
Doctor J. Han (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Electrocardiogram characteristics and risk of atrial fibrillation among patients with sarcoidosis
Doctor M. Herskind (Aalborg, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation epidemiology (1)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Atrial fibrillation miscellaneous
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources